rheumatoid arthritis
Scipher Medicine, Roivant Partner on Rheumatology Drug Discovery
Roivant will integrate data derived from the development and commercialization of Scipher's PrismRA molecular test to inform its drug development pipeline.
Scipher Medicine, Omny Health Partner to Integrate Test Data Into EMR Network
The two firms are hopeful that integrating their respective transcriptomic and clinical datasets will help in the development of new targeted therapies.
Australia's Colonial Foundation Commits A$21M for Inflammatory Disease Dx Research Center
The new center will use spatial omics technology and be led by the Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research (WEHI).
Metabolon, SERA Partner on Research Into Metabolomic Biomarkers for Rheumatoid Arthritis
The project will combine Metabolon's metabolomics platform with SERA's patient samples to study molecular mechanisms of RA development and progression.
Oxford BioDynamics, King's College London to Develop Biomarkers for Rheumatoid Arthritis Prevention
Oxford BioDynamics will use its EpiSwitch 3D genomics platform to develop blood-based biomarkers of disease progression and response to the drug Orencia.